EXPLORE MORE CATEGORIES
- Home
- ยป
- Our Products
- »
- Diabetic Medicine
Diabetic Medicine
Leading Wholesale Trader of glimepiride 1 mg tablets, linagliptin 5 mg, linagliptin (5mg), dapagliflozin(10mg) and metformin hydrochloride (sr) (1000mg), thyroxine sodium 200 mcg, metformin (850mg) & linagliptin 2.5mg and gliclazide ip (40 mg), metformin hydrochloride ip (500 mg), voglibose ip (0.3 mg) from Jaipur.
Glimepiride 1 Mg Tablets
Product Price: Rs 80 / BoxGet Best Price
Product Brochure
Product Details:
| strength | 1 mg |
| Form | Tablets |
| Composition | Glimepiride (1 mg) |
| Packaging Size | 10x30 |
| Packaging Type | Blister |
| Brand | GLIMITERIS 1,GLIMITERIS 1 - Steris Healthcare Pvt Ltd |
| Manufacturer | Steris Healthcare Pvt Ltd |
| Usage | To treat type 2 diabetes |
| Prescription/Non Prescription | Prescription |
| Also gives | PCD Pharma Franchise |
| Country of Origin | Made in India |
Glimepiride 1 mg
Glimiteris 1 mg is an oral diabetes medication that helps control blood sugar levels. Glimiteris 1 mg belongs to a class of drugs called sulfonylureas, which work by stimulating the pancreas to produce more insulin. It's typically prescribed for individuals with type 2 diabetes to help lower their blood sugar levels.
Yes! I am InterestedRequest A Callback
Linagliptin 5 mg
Product Price: Rs 50 / StripeGet Best Price
Minimum Order Quantity: 1 Stripe
Product Brochure
Product Details:
| Strength | 5 mg |
| Form | Tablets |
| Composition | Linagliptin (5 mg) |
| Packaging Size | ( 6x10 ) |
| Brand | LINALIGOLD 5 |
| Prescription/Non prescription | Prescription |
| Also gives | Pharmaceutical Third Party Manufacturing |
| Country of Origin | Made in India |
LinaglipLinagliptin 5 mg
linagliplinagliptin 5 mg improve glycemic control in adults with type 2 diabetes.Linagliptin 5 mg
is often prescribed when diet and exercise alone are insufficient to control blood sugar levels. Linagliptin 5 mg
can be used alone or in combination with other antidiabetic medications such as metformin, sulfonylureas, or insulin.Linagliptin 5 mg
typical dose of Linagliptin is 5 mg taken once daily. Linagliptin can be taken with or without food. Linagliptin 5 mg
is important to take it at the same time each day to maintain consistent blood levels of the medication.Linagliptin works by inhibiting the DPP-4 enzyme, which leads to increased levels of incretin hormones (GLP-1 and GIP). Linagliptin 5 mg
hormones help to:
- Increase insulin secretion from the pancreas in response to meals.
- Decrease the release of glucagon, which lowers the amount of glucose produced by the liver Patients with a history of pancreatitis should use Linagliptin with caution. Unlike many other antidiabetic drugs, Linagliptin does not require dose adjustment in patients with renal impairment.Linagliptin 5 mg
risk of hypoglycemia increases when Linagliptin is used in combination with insulin or sulfonylureas.Patients should discontinue Linagliptin immediately if they experience signs of hypersensitivity. Concomitant use may increase the risk of hypoglycemia.Linagliptin 5 mg
can decrease the effectiveness of Linagliptin by increasing its metabolism.Linagliptin can be safely combined with other antidiabeticmedications, but careful monitoring is necessary to avoid adverse effects.Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 5 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
Yes! I am InterestedRequest A Callback
Linagliptin (5mg), Dapagliflozin(10mg) and Metformin Hydrochloride (SR) (1000mg)
Product Price: Rs 150 / StripGet Best Price
Product Brochure
Product Details:
| Strength | 10 mg / 1000 mg |
| Packaging Size | 10*10 Tablets |
| Pack Size | 10*10 Tablets |
| Brand | LINALIGLIP DAPAMET |
| Manufacturer | Steris Healthcare Pvt Ltd |
| Usage | To Treat Type 2 Diabetes |
| Pack Type | Strip |
| Packaging Type | Box |
LINALIGLIP DAPAMET is a potent combination therapy designed to manage type 2 diabetes effectively. With a synergistic blend of Linagliptin (5mg), Dapagliflozin (10mg), and Metformin Hydrochloride (SR) (1000mg), this medication helps regulate blood sugar levels while addressing multiple aspects of diabetes care. It is a comprehensive solution that enhances glycemic control, reduces insulin resistance, and minimizes the risk of complications associated with diabetes.
Key Benefits:
-
Comprehensive Glycemic Control
- The triple-action formula targets different pathways to maintain optimal blood sugar levels throughout the day.
-
Weight Management
- Dapagliflozin helps reduce excess body weight, a common issue in people with type 2 diabetes.
-
Cardiovascular Benefits
- Proven to lower the risk of cardiovascular events, such as heart attack and stroke, in diabetic patients.
-
Enhanced Insulin Sensitivity
- Metformin improves the body's response to insulin, reducing insulin resistance.
-
Convenience
- Combines three powerful diabetes medications into one tablet, reducing the need for multiple prescriptions and enhancing patient compliance.
LINALIGLIP DAPAMET works through a multi-pronged approach to diabetes management:
- Linagliptin: Inhibits the DPP-4 enzyme, allowing incretin hormones to stimulate insulin release and reduce glucagon levels, thereby lowering blood sugar levels.
- Dapagliflozin: Inhibits SGLT2 in the kidneys, promoting glucose excretion through urine, which helps in both glycemic control and weight loss.
- Metformin (SR): Reduces glucose production in the liver and improves insulin sensitivity, ensuring effective utilization of glucose by the body.
This powerful combination ensures steady blood sugar control while addressing associated complications.
Directions for Use:
-
Dosage
- Take as prescribed by your healthcare provider. Typically, it is taken once daily with meals to minimize gastrointestinal discomfort.
-
Administration
- Swallow the tablet whole with a glass of water. Do not crush, chew, or break it.
-
Consistency
- Use the medication regularly at the same time each day for optimal results.
-
Lifestyle Integration
- Combine the medication with a balanced diet, regular exercise, and routine blood sugar monitoring for the best outcomes.
While LINALIGLIP DAPAMET is generally well-tolerated, some individuals may experience:
-
Common Side Effects:
- Nausea
- Diarrhea
- Mild urinary tract infections
- Headache
-
Rare Side Effects:
- Low blood sugar (hypoglycemia) when combined with insulin or sulfonylureas
- Increased urination
- Allergic reactions such as rash or swelling
If you experience severe side effects or symptoms like persistent stomach pain, difficulty breathing, or signs of infection, seek immediate medical attention.
Yes! I am InterestedRequest A Callback
Thyroxine Sodium 200 mcg
Product Price: Rs 260 / BottleGet Best Price
Minimum Order Quantity: 1 Bottle
Product Brochure
Product Details:
| Strength | 200 mcg |
| Brand | THYRORISE 200 |
| Packaging Size | 120 Tablets |
| Packaging Type | Bottle |
| Brand Name | THYRORISE 200 |
| Manufacturer | Steris Healthcare Pvt Ltd |
| Composition | Thyroxine Sodium 200 mcg |
| Country of Origin | Made in India |
| Shelf Life | 24 months |
Thyroxine Sodium, commonly known as levothyroxine, is a synthetic form of the thyroid hormone used to treat hypothyroidism, a condition where the thyroid gland does not produce enough hormones. THYRORISE 200, with a dosage of 200mcg, helps restore normal hormone levels, improving various bodily functions and overall well-being.
How Does It Work?Thyroxine Sodium works by replacing or supplementing the thyroid hormone that is naturally produced by the thyroid gland. It plays a crucial role in regulating the body's metabolism, energy production, and growth. By increasing thyroid hormone levels, it helps improve symptoms of hypothyroidism, such as fatigue, weight gain, and depression.
Uses of THYRORISE 200- Hypothyroidism Treatment: Restores thyroid hormone levels in individuals with an underactive thyroid gland.
- Goiter Prevention: Helps reduce the size of an enlarged thyroid gland.
- Thyroid Cancer: Used as part of the treatment plan for certain types of thyroid cancer.
THYRORISE 200 is a medication containing 200mcg of Thyroxine Sodium. It is prescribed to patients with thyroid hormone deficiencies to help maintain normal thyroid hormone levels in the body.
Side Effects- Common Side Effects: Headache, sweating, nervousness, and irritability.
- Severe Side Effects: Chest pain, rapid or irregular heartbeat, and shortness of breath. Seek medical attention if these occur.
- Dosage Adherence: Always take THYRORISE 200 exactly as prescribed by your healthcare provider.
- Regular Monitoring: Regular blood tests are essential to monitor thyroid hormone levels and adjust dosage accordingly.
- Interactions: Inform your doctor about any other medications you are taking, as Thyroxine Sodium can interact with certain drugs.
Yes! I am InterestedRequest A Callback
Metformin (850mg) & Linagliptin 2.5mg
Product Price: Rs 50 / BoxGet Best Price
Minimum Order Quantity: 1 Box
Product Brochure
Product Details:
| Strength | 2.5 mg/850 mg |
| Pack Type | Box |
| Brand | LINALIGOLD M 2.5/850 |
| Manufacturer | steris healthcare pvt ltd |
| Prescription/Non Prescription | Prescription |
| Prescription / Non Prescription | Prescription |
| Country of Origin | Made in India |
Metformin (850mg) & Linagliptin 2.5mg
The primary use of this combination is to improve glycemic control in adults with type 2 diabetes. It is usually prescribed when diet, exercise, and single-agent therapy do not provide adequate glycemic control. Metformin works by reducing the amount of sugar produced by the liver, while Linagliptin helps the pancreas release more insulin and decreases the amount of sugar made by the body.Dosage may be adjusted based on individual patient needs, response to treatment, and tolerability. Always follow the prescription guidelines provided by the healthcare provider.: Gastrointestinal issues such as nausea, vomiting, diarrhea, abdominal pain, and a metallic taste in the mouth are commonly reported. Headaches and upper respiratory tract infections are also possible.Lactic acidosis (a rare but serious complication associated with Metformin), pancreatitis, severe allergic reactions, and hypoglycemia when used with other antidiabetic medications. Regular monitoring of kidney function is crucial as Metformin can affect renal function. Patients should also be aware of signs of lactic acidosis, such as muscle pain, difficulty breathing, and abdominal pain.The combination provides a synergistic effect that enhances blood glucose control more effectively than either medication alone.Unlike some diabetes medications, this combination is weight neutral and may even contribute to modest weight loss.Combining two medications into one tablet improves adherence to treatment and simplifies the medication regimen.Decreases hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake and utilization. Inhibits DPP-4, an enzyme that destroys the incretin hormones GLP-1 and GIP. By protecting these hormones, Linagliptin increases insulin release in response to meals and decreases the amount of glucose produced by the liver.Patients with severe renal impairment or dysfunction should not use this medication due to the risk of lactic acidosis with Metformin. Patients with a known hypersensitivity to Metformin, Linagliptin, or any component of the formulation should avoid this medication. Conditions such as diabetic ketoacidosis should be managed appropriately before considering this medication.
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 5 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
Yes! I am InterestedRequest A Callback
Gliclazide IP (40 Mg), Metformin Hydrochloride IP (500 Mg), Voglibose IP (0.3 Mg)
Product Price: Rs 134 / StripeGet Best Price
Product Brochure
Product Details:
| Strength | 0.3 mg |
| Form | Tablets |
| Composition | Gliclazide IP (40 mg), Metformin Hydrochloride IP (500 mg), Voglibose IP (0.3 mg) |
| Packaging Size | For 15 tablets |
| Packaging Type | alu alu |
| Brand | Steris Healthcare Pvt Ltd |
| Prescription/Non prescription | Prescription |
| Country of Origin | Made in India |
GLICLAGLAZE TRIO 40/0.3 is a prescription medication used for managing type 2 diabetes. It contains a combination of three active ingredients—Gliclazide IP (40 mg), Metformin Hydrochloride IP (500 mg), and Voglibose IP (0.3 mg)—each targeting different pathways to help control blood sugar levels.
Key Benefits:
- Provides comprehensive blood sugar control for patients with type 2 diabetes.
- Reduces fasting and post-meal glucose levels.
- Lowers the risk of complications associated with high blood sugar, such as cardiovascular issues and neuropathy.
- Gliclazide enhances insulin secretion from the pancreas.
- Metformin decreases glucose production in the liver and improves insulin sensitivity.
- Voglibose slows the breakdown of carbohydrates in the intestines, minimizing sudden spikes in blood sugar levels after meals.
- Take this medication as directed by your healthcare provider, typically once or twice daily with meals.
- Swallow the tablet whole with water.
- Do not crush or chew the tablet.
- Regularly monitor your blood sugar levels as advised by your doctor.
- Common: Nausea, diarrhea, stomach pain, and low blood sugar (hypoglycemia).
- Less Common: Headaches, dizziness, and mild gastrointestinal discomfort.
- Rare but Severe: Severe hypoglycemia, lactic acidosis (with metformin), or allergic reactions.
Yes! I am InterestedRequest A Callback
Sitagliptin Tablet IP 25 mg
Product Price: Rs 45 / StripGet Best Price
Product Brochure
Product Details:
| Dose/Strength | 25 mg |
| Packaging Type | Box |
| Manufacturer | Steris Healthcare Pvt Ltd |
| Usage/Application | Personal |
| Shelf Life | 24 months |
| Brand Name | ST GLIPTIN 25 |
ST GLIPTIN 25 is a pharmaceutical product containing Sitagliptin, an effective medication used to control blood sugar levels in individuals with Type 2 diabetes mellitus. It belongs to a class of drugs known as DPP-4 inhibitors (dipeptidyl peptidase-4 inhibitors). This medication is often prescribed in combination with other antidiabetic drugs or diet and exercise plans to help manage blood sugar levels and reduce the risk of complications associated with diabetes, such as heart disease, nerve damage, and kidney problems.
Key Ingredients:
- Sitagliptin Tablet IP 25 mg: The active ingredient Sitagliptin works by increasing the levels of incretin hormones, which help regulate insulin production in response to meals. It also lowers the amount of glucose produced by the liver.
- Effective Blood Sugar Control: ST GLIPTIN 25 helps to manage blood sugar levels in adults with Type 2 diabetes, especially when used alongside proper diet and exercise.
- Minimal Risk of Hypoglycemia: Unlike some other diabetes medications, Sitagliptin generally does not cause hypoglycemia (low blood sugar) when used alone.
- Promotes Healthy Insulin Levels: Sitagliptin helps enhance the body’s natural release of insulin after meals, improving overall glucose management.
- Supports Heart Health: Maintaining stable blood sugar levels can reduce the risk of cardiovascular complications, making it an important part of a diabetes management plan.
ST GLIPTIN 25 (Sitagliptin) works by inhibiting the DPP-4 enzyme, which is responsible for breaking down incretin hormones. These hormones play a key role in regulating blood glucose levels by stimulating insulin release and decreasing glucose production in the liver. By inhibiting DPP-4, Sitagliptin increases the levels of active incretin hormones, leading to better control over blood sugar levels, especially after meals.
Directions for Use:
- Dosage: The recommended dose is typically 25 mg taken once daily, as directed by your healthcare provider. This dosage may be adjusted based on the individual's health condition and response to treatment.
- Method: ST GLIPTIN 25 can be taken with or without food. Swallow the tablet whole with a glass of water. To achieve the best results, it's important to take the medication at the same time each day.
- Consistency: It's essential to continue taking ST GLIPTIN 25 as prescribed, even if you feel well. Do not stop the medication without consulting your doctor.
While ST GLIPTIN 25 is generally well-tolerated, some individuals may experience side effects such as:
- Nausea or diarrhea
- Headache
- Upper respiratory tract infections
- Sore throat
- Joint pain
Yes! I am InterestedRequest A Callback
Dapagliflozin 10mg and pioglitazone 15mg tablets
Product Price: Rs 255 / StripGet Best Price
Product Brochure
Product Details:
| Strength | 25mg |
| Pack Type | Strips |
| Brand Name | GLIDAPA PIO |
| Manufacturer | Steris Healthcare Pvt Ltd |
| Usages | As directed by the physician |
| Country of Origin | Made in India |
| Composition | Dapagliflozin 10mg and pioglitazone 15mg tablets |
| Shelf Months | 24 months |
Key Ingredients:
- Dapagliflozin (10mg) is an SGLT2 inhibitor that lowers blood glucose by increasing glucose excretion via urine.
- Pioglitazone (15mg) is a thiazolidinedione that improves insulin sensitivity in muscle, fat, and liver tissues, thereby increasing glucose utilization.
- Helps to improve glycemic control in Type 2 Diabetes Mellitus.
- Reduces insulin resistance and improves glucose uptake in peripheral tissues.
- Increases urinary glucose excretion, which aids in blood sugar reduction.
- Dapagliflozin's glucose-lowering effect helps with weight management.
- Provides cardiovascular benefits by lowering the risk of heart failure hospitalization.
- Provides renal protection by lowering albuminuria and slowing kidney disease progression.
- Improves lipid profile and aids in managing metabolic syndrome components.
GLIDAPA PIO has a dual mechanism of action.
- Dapagliflozin inhibits SGLT2 in the proximal renal tubules, reducing filtered glucose reabsorption and increasing urinary glucose excretion, which lowers plasma glucose levels.
- Pioglitazone activates PPAR-γ, improving insulin sensitivity in adipose tissue, skeletal muscle, and liver. This leads to improved glucose uptake and reduced hepatic glucose output.Together, they provide complementary benefits for blood sugar management and insulin resistance.
- Take GLIDAPA PIO exactly as directed by your healthcare provider.
- Usually taken once a day, with or without food, and ideally at the same time every day.
- Avoid crushing or chewing the tablet; instead, swallow it whole with a glass of water.
- To achieve the best results, follow your doctor's diet, exercise, and lifestyle recommendations.
- Follow your doctor's advice and monitor your blood glucose levels on a regular basis.
- Do not discontinue or change the dosage without first consulting your physician.
- Common side effects include urinary tract infections, genital infections, increased urination, weight gain (due to pioglitazone), and edema (fluid retention).
- Possible gastrointestinal symptoms include nausea, diarrhea, and stomach discomfort.
- There is a risk of hypoglycemia when combined with insulin or sulfonylureas.
- Rare but serious side effects include heart failure exacerbation, bone fractures, bladder cancer risk (associated with long-term pioglitazone use), and ketoacidosis (though uncommon).
- If you experience symptoms such as shortness of breath, sudden weight gain, or painful urination, contact your doctor immediately.
Yes! I am InterestedRequest A Callback
Acarbose 50mg Tablet
Product Price: Rs 131.72 / StripGet Best Price
Product Brochure
Product Details:
| Strength | 50 mg |
| Packaging Type | Strip |
| Packaging Size | 10*10 Tablets |
| Brand | ACARBZONE 50 |
| Manufacturer | Steris Healthcare Pvt Ltd |
| Usage/Application | Hospital |
| Shelf Life | 24months |
| Composition | Acarbose 50mg |
| storage | keep at cool and dry place |
| prescription | Requried |
Acarbose 50 mg is an oral anti-diabetic medication primarily used to manage type 2 diabetes mellitus. It belongs to a class of drugs called alpha-glucosidase inhibitors. By slowing down the digestion and absorption of carbohydrates in the intestine, Acarbose helps prevent sudden spikes in blood sugar levels after meals (postprandial hyperglycemia), which is a key challenge in diabetes management.
Uses of Acarbose 50 mgAcarbose 50 mg is commonly prescribed for:
-
Controlling post-meal blood sugar levels in type 2 diabetes patients.
-
Managing elevated HbA1c levels when diet and exercise alone are insufficient.
-
Reducing the risk of long-term diabetes complications such as cardiovascular issues, kidney damage, and nerve problems.
-
Can be used alone or in combination with other anti-diabetic medications like Metformin or Insulin for better glycemic control.
-
Effective Post-Meal Blood Sugar Control: Slows carbohydrate absorption, reducing sugar spikes after meals.
-
Supports Overall Glycemic Management: Helps lower HbA1c levels over time.
-
Weight Neutral: Unlike some anti-diabetic medications, Acarbose generally does not cause weight gain.
-
Heart-Friendly: May support cardiovascular health indirectly by maintaining stable blood sugar levels.
-
Flexible Use: Can be combined with other diabetes treatments for optimized management.
Acarbose works by inhibiting the alpha-glucosidase enzyme in the intestines. This enzyme breaks down complex carbohydrates into simple sugars. By blocking this process, Acarbose slows the conversion of carbohydrates into glucose, leading to a gradual rise in blood sugar rather than sudden spikes. This mechanism helps improve overall glycemic control and reduces stress on the pancreas.
Dosage and Administration-
Typically taken with the first bite of a meal 2–3 times daily.
-
The dose may be adjusted by your healthcare provider based on blood sugar levels and tolerance.
-
Must be used alongside a proper diet and exercise regimen for best results.
While generally well-tolerated, Acarbose may cause:
-
Gastrointestinal discomfort: Bloating, gas, diarrhea, or abdominal cramps (usually mild and temporary).
-
Rare effects: Liver enzyme changes with long-term use; periodic monitoring may be recommended.
-
Hypoglycemia: Low blood sugar may occur if taken with other anti-diabetic medications; treat promptly with glucose tablets or sugar.
Note: Always consult your doctor before starting Acarbose 50 mg, especially if you have liver disease, digestive disorders, or are pregnant or breastfeeding.
Why Choose Steris Healthcare for Acarbose 50 mg?-
High-Quality Standards: WHO-GMP certified manufacturing ensures purity and safety.
-
Affordable and Accessible: Available across India with reliable distribution.
-
Patient-Centric Approach: Expert guidance for dosage, side effects, and combination therapy.
-
Trusted Brand: Proven efficacy and safety in diabetes management.
Yes! I am InterestedRequest A Callback
dapagliflozin and vildagliptin tablets
Product Price: Rs 121.88 / StripGet Best Price
Product Brochure
Product Details:
| Composition | Vildagliptin 100 mg + Dapagliflozin 5 mg |
| Packaging Size | 6X10 Tablets |
| Packaging Type | Stripe |
| Prescription/Non prescription | Prescription |
| Country of Origin | Made in India |
DAPA VILDA 5/100 SR is an advanced combination medication designed for the effective management of type 2 diabetes mellitus. This pharmaceutical formulation contains two active ingredients: dapagliflozin (5mg) and vildagliptin tablets SR (100mg). Together, these components work through complementary mechanisms to enhance glycemic control and improve overall blood sugar regulation in adults. The dual action targets distinct physiological pathways to lower glucose levels safely and effectively, helping to reduce the risk of diabetes-related complications. This medicine is part of a comprehensive treatment plan that often includes a balanced diet, regular exercise, and other antidiabetic therapies as advised by healthcare professionals.
The medication functions by removing excess glucose from the body and improving insulin action. Specifically, dapagliflozin promotes the removal of excess glucose through urine, while vildagliptin stimulates increased insulin secretion and suppresses excessive glucose production by the liver, offering a balanced approach to managing blood sugar.
What is DAPA VILDA 5/100 SR?
DAPA VILDA 5/100 SR is a fixed-dose combination tablet consisting of 5mg dapagliflozin and 100mg vildagliptin in a sustained-release (SR) form. This unique blend allows for prolonged therapeutic effects, addressing high blood sugar through two mechanisms: dapagliflozin reduces glucose reabsorption in the kidneys, and vildagliptin enhances pancreatic insulin secretion while decreasing liver glucose production.
Uses of DAPA VILDA 5/100 SR
This medication is predominantly used for managing type 2 diabetes mellitus in adults. Its consistent use helps to:
-
Lower blood glucose levels effectively
-
Improve overall glycemic control
-
Support cardiovascular health through blood sugar and weight regulation
-
Reduce the risk of complications such as kidney and heart diseases
-
Complement other diabetes treatments by addressing multiple glucose control pathways simultaneously
Side Effects of DAPA VILDA 5/100 SR
While generally well-tolerated, DAPA VILDA 5/100 SR may cause some side effects. Common and less severe effects include:
-
Increased urination due to excess glucose removal
-
Urinary tract infections and genital infections
-
Headache and dizziness
-
Nausea and mild gastrointestinal discomfort
-
Hypoglycemia, particularly when combined with other antidiabetic drugs
Serious side effects, though rare, require immediate medical attention and may include:
-
Signs of ketoacidosis (nausea, vomiting, abdominal pain)
-
Severe allergic reactions
-
Pancreatitis or liver enzyme elevations
Precautions Before Using DAPA VILDA 5/100 SR
Prior to starting this medication, consider the following precautions:
-
Monitor kidney function regularly, as dapagliflozin can affect renal performance
-
Liver function tests may be necessary due to vildagliptin’s effect on liver enzymes
-
Inform your doctor if you have pre-existing cardiovascular, kidney, or liver conditions
-
Discuss use during pregnancy or breastfeeding with your healthcare provider, as safety has not been established
-
Maintain adequate hydration to reduce the risk of dehydration and urinary infections
-
Be cautious if you have a history of urinary tract infections or hypersensitivity to any ingredients
Yes! I am InterestedRequest A Callback
Linagliptin 5mg and Metformin Hydrochloride (SR) 500mg
Product Price: Rs 229.69 / BoxGet Best Price
Product Brochure
Product Details:
| Strength | 5mg/500mg |
| Brand | LINALIGLIP M 5/500 |
| Manufacturer | Steris Healthcare Pvt Ltd |
| Prescription/Non Prescription | Prescription |
| Country of Origin | Made in India |
LINALIGLIP M 5/500 is a combination medication consisting of Linagliptin 5mg and Metformin Hydrochloride (SR) 500mg. This medication is specifically formulated to help manage type 2 diabetes mellitus by optimizing blood sugar levels and improving overall glycemic control.
How Does It Work?
Linagliptin:
- Inhibits dipeptidyl peptidase-4 (DPP-4)
- Increases insulin release after meals
- Decreases glucagon secretion
Metformin Hydrochloride (SR):
- Increases insulin sensitivity
- Decreases hepatic glucose production
- Slows intestinal glucose absorption
Uses of LINALIGLIP M 5/500
- Primary: Control blood sugar levels in adults with type 2 diabetes
- Supplementary: Improve glycemic control when diet and exercise alone are insufficient
What is LINALIGLIP M 5/500?
- A dual-action therapy for type 2 diabetes
- Combines the benefits of DPP-4 inhibition and insulin sensitization
- Helps maintain steady blood sugar levels
Side Effects
- Common: Gastrointestinal issues such as nausea, vomiting, diarrhea
- Less Common: Headache, upper respiratory tract infection
- Serious: Lactic acidosis, pancreatitis, severe hypoglycemia
Safety Information
- Monitoring: Regularly monitor blood sugar levels and kidney function
- Precautions: Not recommended for patients with severe renal impairment or a history of lactic acidosis
- Interactions: Consult with your healthcare provider about all medications and supplements you are taking
Yes! I am InterestedRequest A Callback
pioglitazone 7.5 mg
Product Price: Rs 55.31 / StripGet Best Price
Product Brochure
Product Details:
| Strength | 7.5 mg |
| Pack Size | 20*10 |
| Pack Type | Strips |
| Brand Name | PIOSTERIS 7.5 |
| Manufacturer | Steris Healthcare Pvt Ltd |
| Usages | Beneficial in patients with insulin resistance or metabolic syndrome. |
| Country of Origin | Made in India |
PIOSTERIS 7.5 is an oral antidiabetic medication containing pioglitazone 7.5 mg, prescribed to help manage blood glucose levels in adults with type 2 diabetes mellitus. It belongs to the thiazolidinedione (TZD) class of drugs and works by improving the body’s sensitivity to insulin. As part of a comprehensive diabetes management plan—including diet and exercise—PIOSTERIS 7.5 helps maintain better glycemic control and reduce the risk of diabetes-related complications.
What is PIOSTERIS 7.5 (Pioglitazone 7.5 mg Tablet)?
PIOSTERIS 7.5 is a pioglitazone tablet containing pioglitazone 7.5 mg, designed for the treatment of type 2 diabetes. It does not increase insulin secretion but works by reducing insulin resistance.
Pioglitazone Mechanism of Action:
Pioglitazone activates peroxisome proliferator-activated receptor gamma (PPAR-γ) in fat cells, muscle, and the liver. This leads to:
-
Improved insulin sensitivity
-
Decreased glucose production by the liver
-
Enhanced glucose uptake by peripheral tissues
This mechanism helps lower blood glucose without causing hypoglycemia when used alone.
Uses of Pioglitazone 7.5 mg
PIOSTERIS 7.5 is used for:
-
Type 2 Diabetes Mellitus: To improve blood sugar control when lifestyle changes or other medications are insufficient.
-
Combination Therapy: Can be used with metformin, sulfonylureas, or insulin when dual therapy is needed.
-
Insulin Sensitization: Beneficial in patients with insulin resistance or metabolic syndrome.
This dose is particularly suitable for patients who require a lower starting dose due to tolerability concerns or to minimize side effects.
Side Effects of Pioglitazone 7.5 mg
Like any medication, pioglitazone 7.5 mg may cause side effects. While many are mild, some may be serious.
Common side effects:
-
Weight gain
-
Fluid retention or swelling (especially in the ankles)
-
Muscle pain or back pain
-
Headache
-
Mild upper respiratory infections
Serious side effects:
-
Heart failure – due to fluid retention
-
Bladder cancer (rare, with long-term use)
-
Bone fractures (more common in women)
-
Macular edema (vision disturbances)
-
Liver dysfunction
Report any signs of shortness of breath, rapid weight gain, unusual fatigue, or yellowing of the skin or eyes to your healthcare provider.
Precautions Before Using Pioglitazone 7.5 mg
Before starting PIOSTERIS 7.5, inform your healthcare provider if you:
-
Have a history of heart failure or cardiovascular disease
-
Have liver problems or elevated liver enzymes
-
Have or have had bladder cancer
-
Are pregnant, trying to conceive, or breastfeeding
-
Consume alcohol frequently
-
Are at increased risk of osteoporosis or fractures
Regular monitoring of liver function and heart health is recommended during treatment.
Drug Interactions – What Drugs Interact with Pioglitazone 7.5 mg?
Pioglitazone may interact with other medications, altering its effectiveness or increasing side effects:
-
Insulin or sulfonylureas – May increase the risk of hypoglycemia and fluid retention
-
Gemfibrozil – Increases pioglitazone concentration and effects
-
Yes! I am InterestedRequest A Callback
Empagliflozin and Linagliptin Tablets
Product Price: Rs 345 / StripGet Best Price
Product Brochure
Product Details:
| Strength | 25mg/5mg |
| Composition | Empagliflozin and Linagliptin Tablets |
| Form | Tablets |
| Packaging Size | FOR 10 TABLETS |
| Packaging Type | BLISTER |
| Manufactured By | Steris Healthcare Pvt Ltd |
| BRAND | EMPATECH |
| SHELF LIFE | 24 MONTHS |
What is the EMPATECH LINA 25/5?
EMPATECH LINA 25/5 is a tablet that contains 25 mg of Empagliflozin and 5 mg of Linagliptin. It is an oral anti-diabetic medication that reduces high blood sugar levels in type 2 diabetes patients by improving the body's glucose and insulin metabolism. This medication takes a dual approach: Empagliflozin reduces glucose reabsorption in the kidneys, causing excess glucose to be excreted in the urine, whereas Linagliptin increases incretin hormone levels, which stimulate insulin release and reduce sugar production by the liver.
Applications of EMPATECH LINA 25/5
- To enhance glycemic control in adults with type 2 diabetes.
- To be used in conjunction with a healthy diet and regular exercise to effectively lower blood sugar.
- May be prescribed for patients who are not adequately controlled on metformin or other antidiabetic medications.
- Helps to reduce the risk of cardiovascular complications caused by type 2 diabetes.
- Suitable for patients who are intolerant to metformin or require multiple drug mechanisms for optimal control.
- Urinary tract infections caused by elevated glucose levels in urine.
- Fungal infections of the genitals.
- Nasopharyngitis (common cold symptoms include nasal congestion and a sore throat).
- Hypoglycemia (low blood sugar), particularly when combined with other diabetes medications.
- Increased urination.
- Thirst and dehydration may occur if there is significant fluid loss.
- In some cases, gastrointestinal symptoms may include nausea, vomiting, or constipation.
- Ketoacidosis is a rare but serious side effect that can occur when acids called ketoacids accumulate in the blood.
- Inform your doctor if you have kidney or liver problems.
- Mention any previous urinary tract or genital infections.
- Pregnancy and breastfeeding status should be communicated; use during these times requires caution.
- Avoid use if you have diabetic ketoacidosis symptoms.
- Ensure that your doctor is aware of all other medications and supplements you are taking.
- Maintain proper hydration to avoid dehydration.
- Regular blood sugar monitoring is essential for avoiding hypoglycemia.
- Use with caution in elderly patients and those with low blood pressure.
Yes! I am InterestedRequest A Callback